Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday
Benzinga
Published Oct 03, 2023 15:09
Updated Oct 03, 2023 16:10
Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday
Benzinga - by Lisa Levin, Benzinga Editor.
U.S. stocks traded lower, with the Nasdaq Composite falling more than 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
- Vericity, Inc. (NASDAQ: VERY) shares climbed 87% to $11.11 after iA Financial Group announced it will acquire the company.
- POINT Biopharma Global Inc. (NASDAQ: PNT) gained 84% to $12.30. Eli Lilly And Co (NYSE: LLY) agreed to acquire POINT Biopharma Global at $12.50 per share in cash, an aggregate of approximately $1.4 billion.
- Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 10.5% to $3.9691. Raymond James upgraded Clean Energy Fuels from Outperform to Strong Buy and announced a $6 price target.
- Warby Parker Inc. (NYSE: WRBY) gained 9% to $14.47. Evercore ISI Group upgraded Warby Parker from In-Line to Outperform and announced a $20 price target.
- Lantheus Holdings, Inc. (NASDAQ: LNTH) climbed 7% to $72.34 possibly after Eli Lilly agreed to acquire POINT Biopharma. Lantheus and POINT are partners for certain cancer programs.
- Oddity Tech Ltd. (NASDAQ: ODD) gained 6.1% to $29.79 after the company reported solid preliminary third-quarter results, allowing it to deliver net revenue growth of at least 58% in the first three quarters of 2023.
- Fiverr International Ltd. (NYSE: FVRR) rose 6% to $25.50. Roth MKM upgraded Fiverr Intl from Neutral to Buy and announced a $33 price target.
- Studio City International Holdings Limited (NYSE: MSC) climbed 5.4% to $5.81.
- NuScale Power Corporation (NYSE: SMR) gained 4.7% to $4.72.
- Synaptics Incorporated (NASDAQ: SYNA) climbed 4% to $91.51. Keybanc maintained Synaptics with an Overweight and raised the price target from $100 to $115.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Read the original article on Benzinga
Get The App
Written By: Benzinga
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.